Lidocaine / prilocaine topical Pregnancy and Breastfeeding Warnings
Lidocaine / prilocaine topical is also known as: Emla, Emla Anesthetic Disc, Oraqix
Lidocaine / prilocaine topical Pregnancy Warnings
In a study, the effect of prilocaine on pre- and postnatal development was examined in rats treated with up to 2.8 times the maximum recommended human dose of prilocaine in lidocaine-prilocaine gel from day 6 of gestation to weaning. There was no evidence of altered postnatal development, viability, or reproductive capacity in any offspring.
Lidocaine-prilocaine topical cream has been assigned to pregnancy category B by the FDA. Animal studies have failed to reveal evidence of impaired fertility or fetal harm. There are no controlled data in human pregnancy. Lidocaine-prilocaine topical cream is only recommended for use during pregnancy when benefit outweighs risk.
Lidocaine / prilocaine topical Breastfeeding Warnings
Lidocaine, and probably prilocaine, are excreted into human milk. Following application of the cream to a nursing mother, the milk:plasma ratio of lidocaine is 0.4 and is not determined for prilocaine. The manufacturer recommends that caution be used when administering lidocaine-prilocaine topical cream to nursing women.
See Also...
- lidocaine/prilocaine cream Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
